Methodology

All entries for: Neurocrine Biosciences Inc.

May 7, 2026

Neurocrine Biosciences Inc.

Orphan Drug Designation

treatment of Friedreich ataxia

Disease Area: Rare Diseases
Source
Scroll to Top